The PCAS Group has a long track record in developing industrial enzymatic processes. Historically, the first process was developed more than a decade ago at our Limay site (1993). We then measured the economic and technical benefits of biotransformation when we scaled it up in a 8,000 L reactor.
Industrial Biocatalysis Scale Up & manufacturing with PCAS-Biosolution
To bridge the gap between lab and plant and to accelerate your projects, PCAS Biosolution has built a dedicated in-house bioprocess development facility including fermentation and downstream processing capabilities based on Protéus facilities and large scale manufacturing of the pharmaceutical actives.
Development : Proteus – Nîmes (France)
Special equipment & bioprocess capacity
Once identified and optimized, biocatalysts are manufactured in suitable amounts for immediate production of commercial scale quantities of intermediates and APIs.
PCAS produces enantio-enriched amino-acid in a 8,000L reactor, 900kg batch size.